Stablecoin Development Corporation News and Activities

Acquisition, funding and merger involving Stablecoin Development Corporation.

• NovaBay Pharmaceuticals will change its company name to Stablecoin Development Corporation on Apr 3, 2026. (posted on April 3 2026).
• Stablecoin Development Corporation has filed its IPO. Its stock ticker will be SDEV. (posted on March 23 2026).

View the org chart displaying its 6 main executives

Most searched biographies at Stablecoin Development Corporation

• Michael Kazley, Chief Executive Officer
• Swan Sit, Director
• Paul Freiman, Chairman of the Board

Create your alert
to follow the executive moves at Stablecoin Development Corporation.

Stablecoin Development Corporation has 1,913 competitors including Sanofi (France), Eli Lilly (United States (USA)) and Moderna (United States (USA)).

Popular M&A news in Pharmaceuticals

• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Contraline has just announced a $93 Million fundraising (posted on June 3 2026).
• Hims & Hers has acquired Eucalyptus (posted on June 2 2026).

Popular contacts in Pharmaceuticals

• Joaquin Duato - Chief Executive Officer and Chairman of the Board at Johnson & Johnson
• Robert Ford - Chief Executive Officer and Chairman of the Board at Abbott
• Jonathan Leff - Director at Larimar Therapeutics

Learn more about the Pharmaceuticals industry

Press releases by Stablecoin Development Corporation

• NovaBay | Press Releases
• NovaBay Pharmaceuticals Announces Expansion of DERMAdoctor Picture Porefect Collection with Launch of 15% Niacinamide Pore Minimizing Serum - NovaBay
• NovaBay Pharmaceuticals to Present at the LD Micro Main Event XV - NovaBay
• NovaBay Pharmaceuticals Announces Significant Orders for DERMAdoctor’s Top-Selling Kakadu C Anti-Aging Serum ahead of the Holiday Season - NovaBay
• NovaBay Pharmaceuticals’ Avenova® and DERMAdoctor® Products to be Featured During the October 11-12 Amazon Prime Early Access Sale - NovaBay
• NovaBay Pharmaceuticals Receives a NYSE American Notice Regarding Low Share Price - NovaBay
• NovaBay Pharmaceuticals to Present at the Ladenburg Thalmann 2022 Healthcare Conference - NovaBay
• NovaBay Pharmaceuticals CEO Issues Letter to Stockholders - NovaBay
• NovaBay Pharmaceuticals to Present at the Virtual Life Sciences Investor Forum - NovaBay
• NovaBay Pharmaceuticals Chief Product Officer Dr. Audrey Kunin to Showcase DERMAdoctor’s Eczema Balm on Return QVC® Appearance - NovaBay
• View more press releases Close

Social media about Stablecoin Development Corporation

• Stablecoin Development Corporation on Wikipedia, Google News & Yahoo Finance
• Stablecoin Development Corporation on LinkedIn, X (Twitter) & YouTube